- Nektar Therapeutics (NASDAQ:NKTR): Q3 EPS of -$0.14 beats by $0.05.
- Revenue of $60.9M beats by $6.56M. (PR)
Nektar Therapeutics beats by $0.05, beats on revenues
Recommended For You
More Trending News
About NKTR Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| NKTR | - | - |
| Nektar Therapeutics | ||